-
Actinomycin D Workflows for RNA Stability
2026-09-13
Actinomycin D provides a practical way to separate transcriptional input from RNA decay, making it useful for mRNA stability, transcriptional stress, and apoptosis studies. This guide translates those workflows to allergic-rhinitis models while clearly distinguishing established findings from assay recommendations.
-
SB203580: Mapping p38-AKT Resistance Networks
2026-09-12
SB203580 is a selective ATP-competitive p38 MAPK inhibitor with value beyond routine pathway blockade. This guide shows how to use it as a mechanistic probe alongside the HDAC8-PLCB1-AKT resistance framework described in a key MEK inhibition study.
-
Realgar Toxicity and the Liver–Brain Ornithine Axis
2026-09-11
The reference study links realgar-derived arsenic toxicity to a liver–brain mechanism in which hepatic OTC inhibition elevates ornithine and intensifies ZBTB7A-mediated suppression of astrocyte glycolysis. Its integrated animal, cellular, single-cell transcriptomic, metabolomic, behavioral, and histopathological evidence identifies ornithine regulation and astrocyte energy failure as connected features of central nervous system injury.
-
Canagliflozin: An Orthogonal Assay Control
2026-09-11
Canagliflozin hemihydrate is more than an SGLT2 tool for glucose metabolism research. This article explains how its negative result in a drug-sensitized yeast mTOR screen can sharpen pathway controls, assay interpretation, and experimental boundaries.
-
Carvedilol Phosphate in IRI Research
2026-09-10
Carvedilol Phosphate is a non-selective beta blocker research reagent with additional alpha-1 blocking activity. Its defined salt form, solvent profile, and storage requirements support controlled cardiovascular pharmacology research and hypothesis-driven ischemia–reperfusion injury studies.
-
3X FLAG Peptide Workflow for Viral Protein Studies
2026-09-10
The 3X (DYKDDDDK) Peptide supports sensitive FLAG fusion-protein detection, competitive elution, and assay development when conventional single-epitope workflows are too weak. This guide connects practical tagging and purification decisions with the SARS-CoV-2 Nsp1–mRNA export study while clearly separating established evidence from recommended follow-up experiments.
-
WM-8014: From KAT6A Inhibition to Senescence
2026-09-09
WM-8014 is a reversible KAT6A inhibitor that connects acetyl-CoA-site competition with cell-cycle arrest and senescence. This article adds a time-aware assay framework inspired by RESTRICT-seq, helping researchers distinguish target engagement from nonspecific toxicity in cancer biology research.
-
2-Deoxy-D-glucose for Immunometabolic Assays
2026-09-09
Discover how 2-Deoxy-D-glucose and 2-DG can be integrated into whole-blood, cancer, and antiviral experiments without confusing metabolic inhibition with nonspecific toxicity. This guide translates standardized immunometabolism methods into practical assay decisions, controls, and interpretation strategies.
-
Tacrolimus (FK506): Reliable Cell Assay Design
2026-09-08
This scenario-driven guide explains how Tacrolimus (FK506), SKU B2143, can improve interpretation of T-cell activation, cytokine, proliferation, and cytotoxicity assays. It covers mechanism, solvent compatibility, concentration selection, metabolic-stress confounders, and practical vendor-selection criteria.
-
Prednisone for Reliable Cell Assays
2026-09-08
This scenario-driven guide explains how Prednisone, SKU B2148, can support interpretable lymphocyte viability, proliferation, cell-cycle, and apoptosis assays. It covers solvent control, dose–time design, matrix-aware interpretation, and practical criteria for selecting a reliable research-grade corticosteroid workflow.
-
Fast-Dissociating Antibodies for Single-Molecule Imaging
2026-09-07
Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific antibodies with unusually rapid dissociation directly from hybridoma cultures. Their Fab probes support multiplexed super-resolution imaging and reveal rapid espin turnover within long-lived F-actin cores of inner-ear stereocilia, showing that fast off-rates can be experimentally useful rather than merely a liability.
-
Anagliptin Vasorelaxation: Kv Channels and SERCA
2026-09-07
A 2025 Acta Diabetologica study shows that Anagliptin relaxes phenylephrine-contracted rabbit aortic rings through pharmacologically supported involvement of voltage-dependent K+ channels and the SERCA pump. The response was independent of the endothelium and canonical cAMP/PKA or cGMP/PKG signaling, providing a focused framework for studying vascular effects beyond the drug’s established DPP-4 inhibition mechanism.
-
PNU 74654: Wnt Signaling Pathway Inhibitor Workflows
2026-09-05
Build reproducible Wnt/β-catenin pathway experiments with PNU 74654, from DMSO stock preparation to reporter, differentiation, and proliferation assays. The workflow emphasizes pathway-direction controls, dose-response design, and careful interpretation when translating findings from muscle progenitors to cancer or stem cell models.
-
CAY10499: Mapping Lipid Flux in Macrophages
2026-09-04
CAY10499, an inhibitor of human hormone sensitive lipase, enables mechanistic separation of lipase activity from ACLY-driven macrophage reprogramming. This article presents an assay strategy for connecting lipid hydrolysis, endocannabinoid turnover, and tumor-associated macrophage biology without overstating translational evidence.
-
Phosbind Acrylamide for TOR Phosphorylation Assays
2026-09-04
Phosbind Acrylamide enables antibody-free visualization of phosphorylation-dependent mobility shifts in proteins linked to TOR signaling. This workflow translates Neurospora nutrient-sensing findings into practical gel-based comparisons while preserving orthogonal controls for localization, complex formation, and phosphatase sensitivity.